Latest Information Update: 28 Oct 1997
At a glance
- Originator NeuroSearch
- Class Antidepressants
- Mechanism of Action Dopamine uptake inhibitors; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 28 Oct 1997 Discontinued-Preclinical for Depression in Denmark (Unknown route)
- 06 Jan 1997 Preclinical development for Depression in Denmark (Unknown route)
- 14 Dec 1995 New profile